← Back
$AVTX All transactions

Avalo Therapeutics, Inc.

A

$ Value

$0

Shares

40,200

Price

$0

Filed

Oct 2

Insider

Name

Lind Kevin Robert

Title

CIK

0001677036

Roles

Director

Transaction Details

Transaction Date

2025-10-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,200

Footnotes

The stock option vests in three substantially equal installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.

Filing Info

Accession No.

0001677036-25-000004

Form Type

4

Issuer CIK

0001534120

Lind Kevin Robert's History

Date Ticker Type Value
2026-03-31 AVTX A $17K
2025-10-01 AVTX A $0

Other Insiders at AVTX (90d)

Insider Bought Sold Last
KAPLAN GILLA 2026-03-28
NEIL GARRY ARTHUR
Chief Executive Officer
2026-03-28
Lind Kevin Robert 2026-03-31
Jain Rita 2026-03-31
Chan Mitchell 2026-03-28
Sullivan Christopher Ryan
Chief Financial Officer
$271K 2026-04-02
KANTOFF AARON 2026-03-28
Doyle Mittie
Chief Medical Officer
$82K 2026-04-06
Goldman Jonathan 2026-03-28
Truex Samantha 2026-03-28